Robert B Bazemore insider trades
Open-market stock purchases and sales by Robert B Bazemore, Director at Akari Therapeutics plc, from SEC Form 4 filings since Sep 23, 2014.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -51%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $0 |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $1 |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $12.5K |
| Oct 14, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $50K |
| Oct 5, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $36.9K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | $103K |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Aug 18, 2026 | AKTX Akari Therapeutics plc | Bought (not open market) | — |
| Jun 16, 2026 | ARDX Ardelyx, Inc | Bought (not open market) | — |
| Jun 16, 2026 | ARDX Ardelyx, Inc | Bought (not open market) | — |
| May 21, 2026 | NUVB Nuvation Bio Inc | Bought (not open market) | — |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $50K |
| Dec 16, 2025 | AKTX Akari Therapeutics plc | Bought | $12.5K |
Companies traded
- AKTX Akari Therapeutics plc: 2 buys, last Oct 14, 2026
- ARDX Ardelyx, Inc: other filings, last Jun 16, 2026
- NUVB Nuvation Bio Inc: 1 buy, last May 21, 2026
- EPZM Epizyme, Inc: 9 sales, last Mar 25, 2021
- NTGN Neon Therapeutics, Inc: other filings, last May 6, 2020
- GEVA Synageva Biopharma Corp: other filings, last Jun 22, 2015